Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

NCT00740207 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Occlusive Disease

Interventions

DRUG: VISIPAQUE 270
DRUG: Isovue 250

Sponsor

Bracco Diagnostics, Inc